Optimizing Physical Access and Affordability Challenges for Branded RX Products: 2024 Branded Pricing Landscape and Approaches to Support Access and Affordability

August 20, 2024 1:00 PM

Historically, trends in branded product pricing have shown predictable year-over-year increases until a generic entrant enters the market. However, 2024 has witnessed an unprecedented proliferation of wholesale acquisition cost (WAC) cuts across the pharmaceutical industry.

In part 2 of our 3-part webinar series, we will explore the magnitude of these cuts in comparison with aggregate trends of previous years.

In this webinar, we’ll dive deep into:

  • Price Cuts in 2024: We’ll analyze the extent of branded product price reductions and the factors driving these changes, including regulatory responses, generic launches, and other influential variables.
  • Balancing Channels & Affordability: Learn about pricing and physical access strategies that manufacturers can use to manage the needs of different distribution channels while still making products more affordable for patients.
  • Optimizing the Product Life Cycle: Discover key stages within a product’s life cycle where these strategies can be implemented for maximum impact. We will discuss preemptive price cuts and product lifecycle pricing considerations.

    Katie Herrick
    Principal Consultant

    Dan DiGiorno
    Principal Consultant

    adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article